Muhammad Shahzeb Khan,Syed Sarmad Javaid,Robert J Mentz et al.
Muhammad Shahzeb Khan et al.
Heart rate variability (HRV) has been reported to predict overall mortality and the risk of cardiovascular disease events in patients, including those with heart failure. However, inconsistent methods of recording and analyzing HRV paramete...
Updates on inherited arrhythmia syndromes (Brugada syndrome, long QT syndrome, CPVT, ARVC) [0.03%]
遗传性心律失常综合征（布鲁加达综合征、长QT综合征、CPVT、ARVC）的最新研究进展
Benjamin M Moore,Thomas M Roston,Zachary Laksman et al.
Benjamin M Moore et al.
The inherited arrhythmia (IA) syndromes are a group of rare and complex conditions that may predispose individuals to ventricular arrhythmias and sudden cardiac death. Our understanding of the genetic architecture underlying these syndromes...
Is it safe to use class 1C antiarrhythmic drugs in patients with coronary artery disease and/or cardiomyopathy? [0.03%]
冠心病和/或心脏衰弱患者可以安全使用第1C类抗心率失常药吗？
Peter G Pantlin,Sahil Bharwani,Mina K Chung et al.
Peter G Pantlin et al.
Class 1C antiarrhythmic drugs (AADs) are a key treatment option for effective rhythm control in several common arrhythmias. Here, we review the relevant background on Class 1C AADs, these drugs' indications and contraindications, and potent...
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience [0.03%]
Inclisiran对家族性高胆固醇血症患者的血脂和血管力学特征影响：来自单个脂质中心真实世界经验的结果
Giosiana Bosco,Francesco Di Giacomo Barbagallo,Maurizio Di Marco et al.
Giosiana Bosco et al.
Background and aims: Familial hypercholesterolemia (FH) is characterized by elevated LDL-C and an increased risk of premature cardiovascular events. Inclisiran is a small interfering RNA that inhibits hepatic PCSK9 synthe...
Pulsed field ablation: The basics relating to effectiveness, durability, and safety [0.03%]
脉冲场消融的基本原理及其有效性、持久性和安全性
Sara Vázquez-Calvo,Deepti Ranganathan,Atul Verma
Sara Vázquez-Calvo
Pulsed field ablation (PFA) represents an innovative energy delivery approach for cardiac arrhythmia treatment, characterized by a favorable safety profile and effective myocardial lesion formation. It has demonstrated high acute pulmonary ...
Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension [0.03%]
高危高血压患者脂质异常与心血管事件的关系
Richard Kazibwe,Jeshuah Jehopio,Christopher L Schaich et al.
Richard Kazibwe et al.
Background: Atherogenic dyslipidemia (AD), characterized by low high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides (TG), is associated with increased cardiovascular disease (CVD) risk. This study eval...
Personalizing risk assessment for transcatheter aortic valve replacement: Value of CT imaging and AI [0.03%]
个性化经导管主动脉瓣置换术风险评估：CT影像和AI的价值
Andrew Lin,Thomas A Treibel,Marc R Dweck
Andrew Lin
First presentation of atherosclerotic cardiovascular disease in previously healthy individuals: The multi-ethnic study of atherosclerosis [0.03%]
动脉粥样硬化性心血管疾病首次发病患者的临床特点——弗明翰心脏研究中的发现
Jonathan Kermanshahchi,Andrew S Kao,Charlotte C Ellberg et al.
Jonathan Kermanshahchi et al.
Aim: To evaluate the first presentation of atherosclerotic cardiovascular disease (ASCVD) in individuals without known ASCVD. Methods: ...
Cardiac implantable electronic devices in pediatric and congenital populations [0.03%]
儿科及先天性心脏病患者的心脏起搏器植入术
Douglas Y Mah,John K Triedman
Douglas Y Mah
Pediatric patients and children and adults with congenital heart disease often will require implantation of cardiac implantable electronic devices (CIEDs) for management of a variety of cardiac rhythm pathologies. The safe and effective use...
A social ecological perspective on interventions to address short sleep duration in adults with coronary heart disease [0.03%]
从社会生态学视角对干预成人冠心病患者睡眠时间不足的措施进行研究
Codie R Rouleau,Sheila N Garland
Codie R Rouleau
Background: Short sleep duration (